{"@type":"dcat:Dataset","accessLevel":"public","bureauCode":["009:38"],"contactPoint":{"fn":"admin","hasEmail":"mailto:HealthData@hhs.gov"},"description":"<p>Section 303 (d) of the Medicare Modernization Act (see Downloads section below) requires the implementation of a competitive acquisition program (CAP) for Medicare Part B drugs and biologicals not paid on a cost or prospective payment system basis. The CAP is an alternative to the ASP (buy and bill) methodology for acquiring certain Part B drugs which are administered incident to a physicians services.</p>\n","identifier":"19543013-7eb3-45b5-8ea0-46c1e563eacb","keyword":["claims","enrollment","national","part-b","physician-services","statistics","vendors"],"language":["en"],"license":"http://opendefinition.org/licenses/odc-odbl/","modified":"2016-04-05","publisher":{"@type":"org:Organization","name":"Department of Health &amp; Human Services"},"title":"Competitive Acquisition for Part B Drugs and Biologicals","programCode":["009:000"]}
